NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- Depressive Disorder, Major
- Depressive Disorder, Treatment Resistant
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02994433
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Charles R Conway, MD Washington University School of Medicine